FDA seeks $8.4B in FY2023 to modernize regulatory infrastructure, prep for future pandemics
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy